ZEISS (Germany) and iCAD, Inc (US) are Leading Players in the Intraoperative Radiation Therapy Market

 The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period. The rising incidence of cancer, technological advancements, and advantages offered by IORT are the major factors driving the growth of the global intraoperative radiation therapy market. Research and clinical trials are also being conducted to expand the applications of IORT; this will add to market growth prospects in the coming years. However, the complexity of this technology is indicative of the need for skilled and trained personnel, which may hinder market growth given a current dearth of manpower in many parts of the world. In addition, physicians prefer conventional radiotherapy to IORT due to the better reimbursement scenario for the former.

To know about the assumptions considered for the study download the pdf brochure

The competitive landscape includes the analysis of the key growth strategies adopted by major players between 2017–2020 to expand their global presence and increase their shares in the global intraoperative radiation therapy market. The key growth strategies adopted by the top players in the market are product launches and approvals, agreements, partnerships, mergers and acquisitions, and expansions. Prominent players in the intraoperative radiation therapy market include ZEISS Group (Germany), iCAD, Inc. (US), Eckert & Ziegler (Germany), Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US), IntraOp Medical, Inc. (US), Isoray, Inc. (US), Becton, Dickinson and Company (US), Sordina IORT Technologies (Italy), Varian Medical Systems, Inc. (US), SeeDos Ltd. (UK), IsoAid LLC (US), Ariane Medical Systems Ltd. (UK), Panacea Medical Technologies Pvt. Ltd. (India), Salutaris Medical Devices (US), Brainlab AG (Germany), RaySearch Laboratories (Sweden), REMEDI Co., Ltd. (South Korea), Merit Medical Systems Inc. (US), Xstrahl Medical (UK), DOSIsoft SA (France), Huiheng Medical (China), Sun Nuclear Corporation (US), and Theragenics Corporation (US).

ZEISS is among the pioneer companies that combined surgery with radiotherapy to develop and introduce intraoperative radiation therapy to the cancer treatment field. The flagship product of the company, INTRABEAM, is one of the most widely used IORT products across the globe. INTRABEAM is a revolutionary, intraoperative form of radiation therapy for early-stage breast cancers. It allows radiation treatment and breast-conserving surgery to be performed simultaneously. As a result, the need for several weeks of external radiation therapy following surgery can often be minimized or eliminated. The strong foothold of the company in the intraoperative radiation therapy market can be attributed to its wide geographic reach. ZEISS has a direct presence in almost 50 countries and more than 30 production sites and 25 R&D facilities. ZEISS has a sound custom services support set up, which helps it to strengthen its customer relationships and presence in the market.

iCAD, Inc. is a major player in the intraoperative radiation therapy market. The company offers a wide range of IORT products, including electronic brachytherapy products, different types of applicators, and accessories. In the last three years, the company has significantly invested in R&D activities to launch advanced products in the market. In 2019, the company invested USD 9.4 million in R&D.

Related Reports:

Intraoperative Radiation Therapy Market by Technology (Electron IORT, Brachytherapy), Products & Services (Accelerators, Treatment Planning system, Applicators, Afterloaders, Accessories), Application (Breast, Brain, Lung Cancer) - Global Forecasts to 2025

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Human Microbiome Market Forecast 2025–2031: Driving Healthcare Innovation

Image
  Why the Human Microbiome Matters in 2025 The human microbiome —the trillions of microorganisms living inside the human body—is no longer just a topic for researchers. In 2025, it stands at the center of healthcare innovation , reshaping how we approach precision medicine, gut health, and therapeutic development . From microbiome-based therapies to diagnostics and probiotics, this rapidly expanding sector is capturing the attention of investors, biotech firms, and healthcare providers worldwide . According to the latest market research, the global human microbiome market, valued at US$0.91 billion in 2024, rose to US$1.40 billion in 2025 . It is projected to advance at a remarkable CAGR of 31.0% from 2025 to 2031 , culminating in an estimated US$7.09 billion by 2031 . This explosive growth highlights the increasing relevance of microbiome research in shaping the future of medicine . Download PDF Brochure:  Market Growth Insights & Trends The human microbiome ma...
Read more

Endoscopy Equipment Market Set to Reach USD 53.54 Billion by 2030 | Key Trends, Growth Drivers & Forecast

Image
  The global endoscopy equipment market is on a strong growth trajectory, projected to reach USD 53.54 billion by 2030 , up from USD 37.08 billion in 2025 , registering a CAGR of 7.6% (2025–2030). According to the latest MarketsandMarkets™ report , this surge is fueled by rising demand for minimally invasive procedures , rapid advancements in robot-assisted and AI-integrated endoscopy systems , and increasing day-care and outpatient surgical volumes worldwide. Market Overview: Why Endoscopy Equipment Demand Is Rising The endoscopy devices market has witnessed significant innovation in recent years. Growing cases of gastrointestinal (GI), pulmonary, and urological disorders are driving procedural volumes across hospitals and ambulatory surgical centers (ASCs). Key factors fueling market growth include: Rising patient preference for minimally invasive surgeries (MIS) that reduce pain, hospital stay, and recovery time. Increased adoption of disposable...
Read more

Empty Capsules Market Trends and Competitive Analysis - Exclusive Report by MarketsandMarkets™

Image
  The newly released exclusive study titled "Empty Capsules Market" guarantees that you will be better informed than your competitors. This study provides a comprehensive perspective of the market along with in-depth market insight and analysis that makes survival and success in the market easier. The market report presents the best market and business solutions for the Compound Management industry in this increasingly revolutionary market. Browse and in-depth TOC on "Empty Capsules Market" 176 - Tables 40 - Figures 216 - Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218018190 According to the new market research report "Empty Capsules Market is projected to reach USD 3.7 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 7.2% during the forecast period. Some of the Leading Players in the Empty Capsules Market The prominent players operating in the Empty Capsules Market are Capsugel (US), ACG World...
Read more